Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060530
Filing Date
2025-04-30
Accepted
2025-04-30 06:06:35
Documents
18
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A idya-20250430.htm   iXBRL DEF 14A 1246741
2 GRAPHIC img42977548_0.jpg GRAPHIC 347941
3 GRAPHIC img42977548_1.jpg GRAPHIC 294104
4 GRAPHIC img42977548_2.jpg GRAPHIC 325582
5 GRAPHIC img42977548_3.jpg GRAPHIC 109065
6 GRAPHIC img42977548_4.jpg GRAPHIC 67975
  Complete submission text file 0000950170-25-060530.txt   4917499

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20250430.xsd EX-101.SCH 41406
20 EXTRACTED XBRL INSTANCE DOCUMENT idya-20250430_htm.xml XML 314083
Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38915 | Film No.: 25890663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)